Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
NCT06769776

Drain vs No Drain After Live Donor Hepatectomy

Led by Marengo Asia Hospitals · Updated on 2026-01-06

80

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prophylactic abdominal drain placement after donor hepatectomy has been a common or even mandatory practice in most transplant centers. This serves to monitor the occurrence of post-operative intra-abdominal bleeding and is used for the detection and drainage of any bile leakage. However prophylactic drain placement is not without complications, like; Increased rates of intraabdominal and wound infection, Increased abdominal pain, Decreased pulmonary function, Bowel injury and Prolonged hospital stay. Comprehensive Complication Index (CCI) is a valuable tool used to assess the overall morbidity of patients after surgical interventions . The CCI score ranges from 0 (no complication) to 100 (death), reflecting the gravity of the overall complication burden on the patient on a continuous scale and is a validated tool for living donor liver transplants. The investigators aim to compare the safety of no drain placement vs abdominal drain placement in LDLT(Live Donor Liver Transplant) by comparing the comprehensive complication index(CCI) between both arms at day of discharge after donor hepatectomy.

CONDITIONS

Official Title

Drain vs No Drain After Live Donor Hepatectomy

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing donor hepatectomy
Not Eligible

You will not qualify if you...

  • Patients who do not consent to participate in the study
  • Patients in the no-drain group requiring drain placement during surgery due to surgical reasons
  • Patients undergoing inverted L or J shaped incision
  • Patients undergoing laparoscopic donor hepatectomy
  • Patients undergoing robotic donor hepatectomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Marengo Asia Hospitals

Faridabad, Haryana, India, 121002

Actively Recruiting

Loading map...

Research Team

B

Bharat Nair, MCh

CONTACT

P

Priyanka Tripathi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here